These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1436314)

  • 1. Correlation between tubulointerstitial nephropathy and glomerular lesions induced by adriamycin.
    Güezmes A; Fernández F; Garijo F; Val-Bernal F
    Nephron; 1992; 62(2):198-202. PubMed ID: 1436314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice.
    Turnberg D; Lewis M; Moss J; Xu Y; Botto M; Cook HT
    J Immunol; 2006 Sep; 177(6):4094-102. PubMed ID: 16951374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of allopurinol in the course of adriamycin induced nephropathy.
    Carvalho MF; Viero RM; Soares VA
    Ren Fail; 1999 Mar; 21(2):147-54. PubMed ID: 10088175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary protein, angiotensin I converting enzyme inhibition and mesangial overload on the progression of adriamycin-induced nephropathy.
    Barretti P; Viero RM; Soares VA
    Braz J Med Biol Res; 1995 Jan; 28(1):39-50. PubMed ID: 7581027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hemolytic uremic syndrome as a complication of adriamycin nephropathy.
    Viero RM; Soares VA
    Ren Fail; 1998 Jul; 20(4):565-71. PubMed ID: 9713874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotic syndrome induced by dibasic sodium phosphate injections for twenty-eight days in rats.
    Tsuchiya N; Torii M; Narama I; Matsui T
    Toxicol Pathol; 2009 Apr; 37(3):270-9. PubMed ID: 19244217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular morphometry of adriamycin-induced focal and segmental glomerulosclerosis in the rat.
    Güezmes A; Fernández F; Garijo F; Val-Bernal F
    Am J Nephrol; 1992; 12(6):437-41. PubMed ID: 1292343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adriamycin-induced chronic proteinuria: a structural and functional study.
    O'Donnell MP; Michels L; Kasiske B; Raij L; Keane WF
    J Lab Clin Med; 1985 Jul; 106(1):62-7. PubMed ID: 4009023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of chronic adriamycin nephropathy in leukopenic rats.
    Ginevri F; Trivelli A; Mutti A; Bergamaschi E; Fabbretti G; Callea F; Salvidio G; Altieri P; Perfumo F; Ghiggeri GM
    Nephron; 1993; 63(1):79-88. PubMed ID: 8446256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of urine volume ameliorates adriamycin-induced nephropathy.
    Soares VA; Viero RM
    Braz J Med Biol Res; 1993 Sep; 26(9):943-53. PubMed ID: 8298529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of glomerular barrier function in early adriamycin nephrosis of MWF rats.
    Soose M; Haberstroh U; Rovira-Halbach G; Brunkhorst R; Stolte H
    Clin Physiol Biochem; 1988; 6(6):310-5. PubMed ID: 3208483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture.
    Nagata M; Schärer K; Kriz W
    Kidney Int; 1992 Jul; 42(1):136-47. PubMed ID: 1635343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adriamycin-induced glomerulosclerosis in the rat.
    Bertani T; Rocchi G; Sacchi G; Mecca G; Remuzzi G
    Am J Kidney Dis; 1986 Jan; 7(1):12-9. PubMed ID: 3510531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCV-116 inhibits renal interstitial and glomerular injury in glomerulosclerotic rats.
    Shibouta Y; Chatani F; Ishimura Y; Sanada T; Ohta M; Inada Y; Nishikawa K
    Kidney Int Suppl; 1996 Jun; 55():S115-8. PubMed ID: 8743529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin reduces proteinuria and modulates glomerular TNF-alpha production in the early phase of adriamycin nephropathy.
    Benchetrit S; Golan E; Podjarny E; Green J; Rashid G; Bernheim J; Hershkovitz R; Bernheim J
    Nephron; 2001 Feb; 87(2):155-60. PubMed ID: 11244311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional morphometric analysis of segmental glomerulosclerosis in the rat.
    Remuzzi A; Pergolizzi R; Mauer MS; Bertani T
    Kidney Int; 1990 Nov; 38(5):851-6. PubMed ID: 2266668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial mononuclear cell infiltrates in experimental nephrosis: effect of PAF antagonist.
    Mampaso FM; Egido J; Martínez-Montero JC; Bricio T; González E; Cobo ME; Pirotzky E; Braquet P; Hernando L
    Nephrol Dial Transplant; 1989; 4(12):1037-44. PubMed ID: 2517324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.
    Wang Y; Wang YP; Tay YC; Harris DC
    Kidney Int; 2000 Oct; 58(4):1797-804. PubMed ID: 11012915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.
    Vielhauer V; Berning E; Eis V; Kretzler M; Segerer S; Strutz F; Horuk R; Gröne HJ; Schlöndorff D; Anders HJ
    Kidney Int; 2004 Dec; 66(6):2264-78. PubMed ID: 15569315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.